🇺🇸 FDA
Pipeline program

Hydroxypropyl Guar Galactomannan

C-07-54

Phase 2 small_molecule completed

Quick answer

Hydroxypropyl Guar Galactomannan for Dry Eye Disease is a Phase 2 program (small_molecule) at Alcon Laboratories (Australia) Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Alcon Laboratories (Australia) Pty Ltd
Indication
Dry Eye Disease
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials